Trials and tribulations in drug development for nonalcoholic steatohepatitis
dc.contributor.author | Sanyal, Arun J. | |
dc.contributor.author | Chalasani, Naga | |
dc.contributor.department | Department of Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2017-01-13T18:11:36Z | |
dc.date.available | 2017-01-13T18:11:36Z | |
dc.date.issued | 2014-12 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Sanyal, A. J., & Chalasani, N. (2014). TRIALS AND TRIBULATIONS IN DRUG DEVELOPMENT FOR NONALCOHOLIC STEATOHEPATITIS. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 12(12), 2104–2105. http://doi.org/10.1016/j.cgh.2014.08.005 | en_US |
dc.identifier.issn | 1542-7714 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/11793 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.cgh.2014.08.005 | en_US |
dc.relation.journal | Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Gastrointestinal Agents | en_US |
dc.subject | therapeutic use | en_US |
dc.subject | Non-alcoholic fatty liver disease (NAFLD) | en_US |
dc.subject | drug therapy | en_US |
dc.subject | Stilbenes | en_US |
dc.title | Trials and tribulations in drug development for nonalcoholic steatohepatitis | en_US |
dc.type | Article | en_US |